Correlating Heart Rate Variability and Chronic Pain
Unknown statusNCT05283070
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
The Canadian Armed Forces (CAF) has limited data on baseline quality of life measures and objective measures of function, for active serving members with chronic pain. This study aims to collect this data using patient reported outcomes and 2 minute walk test (2MWT) while validating the newly created Elevation Movement Lift Off Test (EMLi) and correlating the data with heart rate variability (HRV) while comparing performance to healthy controls
Study details
- Official title
- Comparing Patient Reported Outcomes to Objective Measures of Function in Patients With Chronic Pain: Using the 2 Minute Walk Test and Elevation and Movement Lift Test, and Heart Rate Variability
- Conditions
- Interventions
- Other: Questionnaires, physical tests, and heart rate variability measures
- Sponsor
- Canadian Forces Health Services Centre Ottawa
- Start date
- 2021-10-01
- Primary completion
- 2023-12-01
- Sex
- All
- Age range
- from 18 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Countries
- Canada
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * for patients male and female between 18 and 60 years old * seen within the CFO-P * diagnosed with one or more chronic pain condition Exclusion Criteria: * adults who are unable to give their own consent * adults with uncontrolled mental health issues For Controls * Pacemaker/Cardiac Issues * SSRI/Beta Blocker/Anticholinergic medication use in controls * Migraine, cold medication, antihistamine, drugs use (ie cannabis \<48hours) Patients/controls will be asked * to bring exercise attire including running shoes, * not to drink alcohol within 24 hours of testing, * not to consume caffeinated products (ie energy drinks or tea/coffee) within 2 hours of the testing, * not to eat within 2 hours of testing, * not to participate in intense exercise for 24 hours before testing, * not to use nicotine products (smoke, vaping, and tobacco) in the 2 hours before testing, * not to use plant-based cannabis products 2 hours before testing * to use the bathroom before testing.
Canadian sites (1)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05283070